Peer Reviewed Publications

Peer Reviewed Publications 1. Molloy DW, Hyland M. Maintenance salbutamol in chronic bronchitis in the elderly. Age and Aging 1980; 9:272-74. 2. Mo...
Author: Lindsay Welch
2 downloads 0 Views 339KB Size
Peer Reviewed Publications 1.

Molloy DW, Hyland M. Maintenance salbutamol in chronic bronchitis in the elderly. Age and Aging 1980; 9:272-74.

2.

Molloy DW, Murphy C, Fahy G, Cotter P, Molloy M. Polyarteritis and acute myeloid leukemia. Irish J of Med Sci. 1981; 150:158-59.

3.

Molloy DW, Foley B, Buckley D. Incidence and diagnosis of dermatophyte fungal diseases in Cork City and County. Irish J of Med Sci 1981; 150:178-81.

4.

Molloy DW, English J, O'Dwyer R, O'Connell J. Clinical findings in the diagnosis of proximal deep vein thrombosis. Irish Med J 1982; 75:119-21.

5.

O'Neill, Callaghan N, Stapleton M, Molloy DW. Serum elevation of high density lipoprotein (HDL) cholesterol in epileptic patients taking Carbamazepine or Phenytoin. Acta Neurologica Scandinavica 1982; 65:104-9.

6.

English J, Molloy DW, Murnaghan D, Whelton M. Leptospirosis in South West Ireland. Irish J Med Sci 1983; 152:145-49.

7.

Lee KY, Molloy DW, Slyderman L, Prewitt RM. Effects of Hydralazine and Nitroprusside on cardiopulmonary function when a decrease in cardiac output complicates a short term increase in pulmonary vascular resistance. Circulation 1983; 68:1299-303.

8.

Buckley DB, English J, Molloy DW, Doyle CT, Whelton MJ. Dermatitis herpetiformis: A Review of 119 Cases. Clin and Exper Dermatol 1983; 8:477-87.

9.

Molloy DW, Dhingra S, Solven F, Wilson A, McCarthy DS. Hypomagnesaemia and respiratory muscle power. Am Rev Respir Dis 1984; 129:497-98.

10.

Molloy DW, Penner SB, Rabson J, Hall KW. Use of sodium bicarbonate to treat tricyclic antidepressant-induced arrythmias in a patient with alkalosis. Can Med Assoc. J 1984; 137:1457-59.

11.

Molloy DW, Dobson K, Girling L, Greenberg ID, Prewitt RM. Effects of dopamine on cardiopulmonary function and left ventricular volumes in patients with acute respiratory failure. Am Rev Respir Dis 1984; 130:396-99.

12.

Molloy DW, Lee, KY, Girling L, Schick U, Prewitt RM. Treatment of shock in a canine model of pulmonary embolism. Am Rev Respir Dis 1984; 130:870- 74.

13.

Molloy DW, Lee KY, Jones D, Penner B, Prewitt RM.Effects of Noradrenaline and Isoprotererenol on cardiopulmonary function in a canine model of acute pulmonary hypertension. Chest 1985; 88:432.

14.

Molloy DW, Lee KY, Girling L, Prewitt RM. Treatment of canine permeability pulmonary edema: Acute effects of Dobutamine, Lasix, and Hydralazine. Circulation 1985; 72:1365-71.

15.

Molloy DW, Keohane C, Whelton MJ. Atypical Werner-Morrison Syndrome. Irish Med J 1985; 78:100-1.

16.

Molloy DW, Ducas J, Dobson K, Girling L, Prewitt RM. Hemodynamic management in clinical acute hypoxemic respiratory failure: Dopamine versus Dobutamine. Chest 1986;89:636-40.

17.

Wilson A, Sitar DS, Molloy DW, McCarthy D. Effects of age and chronic obstructive pulmonary disease on the breathalyser estimation of blood alcohol level. Alcoholism: Clinical and Experimental Research 1987; 11.

18.

Molloy DW. Memory loss, confusion and disorientation in an elderly woman taking Meclizine. J Am Geriatr Soc 1987; 35:454.

19.

Molloy DW, Seliske J, Cape RDT. Survey of the use of ant cholinergic medications in the institutionalized elderly. J of Clin and Exp Gerontology 1987; 9:231-42.

20.

Molloy DW, Brooymans MA, Borrie MJ.Atypical chest pain in an elderly woman - A case report. Can J of Cardiology. 1988; 4:144-45.

21.

Molloy DW, Beerschoten D, Borrie MJ, Crilly RG, Cape RDT. Acute effects of exercise on neuropsychological function in the elderly. J Am Geriatr Soc 1988; 36:2933.

22.

Molloy DW, Richardson LA, Crilly RG. The effects of a three months exercise program on neuropsychological function in very elderly institutionalized females. Age and Aging 1988; 17:303-10.

23.

Angle MR, Molloy DW, Penner B, Jones D, Prewitt RM. The cardiopulmonary and renal hemodynamic effects of Norepinephrine in canine pulmonary embolism. Chest 1989; 95:1333-37.

24.

Molloy DW, Cape RDT. Acute effects of oral Pyridostigmine on memory and cognitive function in SDAT. Neurobiol Aging. 1989; 10:2.

25.

Molloy DW, Brooymans MA. Ant cholinergic medications and cognitive function in the elderly. J of Clin and Exp. Gerontology 1988; 10:89-98.

26.

Molloy DW, Alemayehu E, Roberts R. Reliability of a Standardized Mini Mental State Examination. Am J Psychiatry 1991; 148:102-105.

27.

Molloy DW, Guyatt G, Wilson D, Duke B, Rees L. Effects of T.H.A on cognition, behaviour, and the ability to perform the activities of daily living in Alzheimer's disease. Can Med Assoc J 1991; 144:29-34.

28.

Molloy DW, Clarnette R, Braun A, Eisemann M. Decision making in the incompetent elderly: The Daughter from California Syndrome. J Am Geriatr Soc 1991; 39:396-99.

29.

Molloy DW, McIlroy W, Guyatt G. Validity and reliability of the Dysfunctional Behaviour Rating Instrument. ACTA Psychiatr. Scand 1991; 84:103-6.

30.

Molloy DW, McIlroy W, Guyatt G, Rees L, Lever J. Clinical significance of primitive reflexes in dementia. J Am Geriatr Soc 1991; 39:1160-63.

31.

Alemeyahu E, Molloy DW, Guyatt GH, Singer J, Penington G, Basile J, Eisemann M, Finucane P, McMurdo MET, Powell C, Zelmanowicz A, Puxty J, Power C, Vitou L, Levenson SA, Turpie ID. Variability in physicians' decisions on caring for chronically ill elderly patients: an international study. Can Med Assoc J 1991; 144:133-38.

32.

Molloy DW, Guyatt G, Alemayehu E, McIlroy W. Treatment preferences, attitudes towards advance directives and concerns about health care. Humane Medicine 1991; 7:285-90.

33.

Molloy DW, Guyatt G, Alemayehu E, McIlroy W, Willan A, Eisemann M, Abraham G, Basile J, Penington G, McMurdo MET, Finucane P, Zelmanowicz A, Hyland M.Factors effecting physicians’ decisions on caring for an incompetent elderly patient: An international study. Can Med Assoc J 1991; 145:947-52.

34.

Molloy DW, Guyatt G.A comprehensive Health Care Directive in a Home for the Aged. Can Med Assoc J 1991; 145:307-11.

35.

Lever JA, Molloy DW, Eisemann M, Eisenmann M, McMurdo MET, Finucane P, Guyatt GH, Rees L, Horsman JR. Variability in nurses' decisions about the care of chronically ill elderly patients - An international study. Humane Medicine 1991; 8:13844.

36.

Molloy DW, Orange JB. Readers left to search (letter). Can Med Assoc J 1992; 146:544-46.

37.

Molloy DW, Cranney A, Krajewski A, Lever JA, Orange JB, Davidson W. Family conference in geriatrics. Can Fam Physician 1992; 38:585-88.

38.

Molloy DW, Cunje A. Hypodermoclysis in the care of older adults - An old solution for new problems? Can Fam Physician 1992; 38:2038-43.

39.

Urbanyi M, Molloy DW, Lever JA. Health care directives for the elderly. Can Fam Physician 1992; 38:2357-361.

40.

Molloy DW, Guyatt G, Brown G. Effects of Oxiracetam on cognition, behaviour and activities of daily living in dementia. J Clin Exp Gerontol 1992; 14:217-33.

41.

Clarnette R, Molloy DW, McIlroy WE, Lever J, Rees L. Maternal age and Alzheimer’s disease. A case control study and literature review. Dementia 1992; 3:32-37.

42.

Molloy DW, Farrugia M, Cunje A. The Canadian experience with advance treatment directives. Humane Medicine 1992; 9:70-7.

43.

Molloy DW, Urbanyi M, Horsman J, Guyatt GH Bédard M. Two years experience with a comprehensive health care directive in a Home for the Aged. Annals RCPSC 1992; 25:433-36.

44.

Molloy DW, Darzins P. Change "DNR" to "GPC" (letter). Med J Australia 1992; 157:425.

45.

Molloy DW. Hypodermoclysis and dehydration (reply). Can Fam Physician 1993; 38:2803-05.

46.

Molloy DW. Appropriate use of hypodermoclysis (reply). Can Fam Physician 1993; 39:24-6.

47.

Molloy DW, Guyatt GH, Standish T, Willan A, McIlroy W, D'Souza J, Brown G, Mondadori C. Effects of a new nootropic agent, CGS 5649B on cognition, function, and behaviour in dementia. J Gen Int Med 1993;444-447.

48.

Molloy DW, Clarnette R. Let Me Decide (letter). Can Med Assoc J 1993; 149:143-44.

49.

Darzins P, Molloy DW, Harrison C. Treatment for life-threatening illness (letter). N Eng J Med 1993; 329:36.

50.

Molloy DW, Eagle DJ, Butt G, Bédard M, Millar P, Stiles T. Use of physical restraints and their relationship to medication use in patients in four different institutional settings. Humane Medicine 1994; 10:17-27.

51.

Davidson W, Molloy DW, G Somers, M Bédard. Relation between physician characteristics and prescribing for elderly people in New Brunswick. Can Med Assoc J 1994; 150:917-21.

52.

Ganesan R, Standish T, Molloy DW, Darzins P, Orange JB. New treatments for dementia: myth, magic and science. Canadian Family Physician 1994:40; 1149-57.

53.

Molloy DW, Bédard M, Davidson WAS, Somers G. "Busy" practices revisited (editorial). Humane Medicine 1994; 10:170-1.

54.

Davidson W, Molloy DW, Somers G, Bédard. Prescribing practices (Reply). Can Med Assoc J 1994; 151:142-44.

55.

Orange JB, Molloy DW. Alzheimer's disease: Physician-patient communication. Canadian Family Physician 1994; 40:1160-8.

56.

Butt G, Molloy DW, Williams R. Three years experience with an innovative geriatric outreach program in a rural community. Annals RCPSC 1994; 27:471-5.

57.

Harrison C, Molloy DW, Darzins P, Bédard M. Should people do unto others as they would not want done unto themselves? J Clin Ethics 1995; 6:14-9.

58.

Figueredo AT, Fawcet, SE, Molloy DW, Dobranowski J, Paulseth JE.Encephalopathy during 5-Fluorouracil and Levamisole as adjuvant therapy for resected colon carcinoma. Cancer Investigation 1995;13:608-11

59.

Lever JA, Molloy DW, Bédard M, Eagle DJ. Pilot study examining the effects of a new policy of least restraint. Perspectives 1995; 19:3-8.

60.

Davidson W, Molloy DW, Bédard M.Physician practice characteristics and prescribing behaviour: Effects on morbidity and mortality among their elderly patients in New Brunswick, Canada. Can Med Assoc J 1995; 152:1227-34.

61.

Bédard M, Molloy DW, Standish T, Guyatt GH, D'Sousa J, Mondadori C, Darzins PJ. Clinical trials in cognitively impaired older adults: Home vs. clinic assessments. J Am Geriatr Soc 1995; 43:1127-30.

62.

Davidson W, Molloy DW, Bédard M. Prescribing for the Elderly in NB. (Reply) Can Med Assoc J 1995; 153:140.

63.

Bédard M, Davidson W, Molloy DW. Prescribing for Elderly People in NB: Where do the figures point? (Reply) Can Med Assoc J 1995; 153:517-8.

64.

Cook DJ, Guyatt GH, Jaeschke R, Reeve J, Spanier A, King D, Molloy DW, Willan A, Streiner D.Determinants in Canadian health care workers of the decision to withdraw life support from the critically ill. JAMA, 1995; 273:703-8.

65.

Molloy DW, Lever JA, VandenBerg A, Principi E, Tuttle I, Strang DG, Salama S, Bédard M, Naglie G. Effects of geriatric assessment in elderly orthopedic patients on length of hospital stay. Annals RCPSC 1995; 28:1-4.

66.

Lever JA, Molloy DW, Bédard M, Eagle JA. Reduction of restraint use through policy implementation and education, Perspectives,1995;19:3-8

67.

Guyatt GH, Mitchell A, Molloy DW, Capretta R, Horsman J, Griffith L. Measuring patient and relative satisfaction with level or aggressiveness of care and involvement in care decisions in the context of life threatening illness. J. Clin Epidemiol 1995; 48; 1215-24.

68.

Set Me Free - Toward more appropriate use of Physical Restraints: Untie the Elderly, 1995; 7:1-2.

69.

Molloy DW, Silberfeld M, Darzins P, Guyatt GH, Singer PA, Rush B, Bédard M. Strang D. Measuring capacity to complete an advance directive. J Am Geriatr Soc 1996; 44:660-4.

70.

Standish T, Molloy DW, Bédard M, Layne EC, Murray EA, Strang DG. Improved Reliability of the Standardized Alzheimer's Disease Scale (SADAS) Compared to the Alzheimer's Disease Assessment Scale (ADAS). J Am Geriatr Soc 1996; 44:712-16.

71.

Molloy DW, Bédard M, Lever JA. Burden in caregivers of cognitively-impaired older adults: The relationship with dysfunctional behaviours, activities of daily living and mood. Annals RCPSC 1996; 29:151-4.

72.

Prinicpi E, Lever JA, Vertesi A, Molloy DW, Tuttle IM. Use of Multiskilled Assessors On An Interdisciplinary Geriatric Team, Physiotherapy Canada 1996;48:102-6

73.

James J, Molloy DW, Urbanyi M, Rapelje DH. The Right To Die With Dignity, Health Care Management June 1996; 78-82.

74.

Bédard M, Molloy DW, Standish T, Guyatt GH, D'Sousa J, Mondadori C, Darzins PJ. Ensaios clinicos em adultos isodos prejuízo cognitivo: Avaliaçoes no lar versus na clinica. Focus em Demência 1996; 1:22-24.

75.

Molloy DW, Jubelius R, Parish S. Implementing advance directives across care sectors. Canadian Health Care Management November 1996:143-6.

76.

Strang D, Gagnon M, Molloy DW, Bédard M, Darzins P, Etchells E, Davidson W.National survey on the attitudes of Canadian physicians towards drug-detailing by pharmaceutical representatives. Annals RCPSC 1996; 29:474-8.

77.

Jaeschke R, Guyatt G, Gerstein H, Patterson C, Molloy DW, Cook D, Harper S, Griffith L, Carbotte R.Does treatment with L-thyroxine influence health status in middle-aged and older adults with subclinical hypothyroidism? J Gen Intern Med 1996; 11:744-9.

78.

Bédard M, Darzins P, Molloy DW. Driver ability vs. crash risk. Aust J Ageing 1996; 1:147.

79.

Molloy DW, Bédard M, Guyatt GH, Lever JA,Dysfunctional behaviour rating instrument. Int Psychogeriatr 1996; 8:333-41.

80.

Molloy DW, Bédard M, Guyatt GH, Patterson C, North J, Jubelius R, Hassard J, Willison K, Darzins P, Harrison C. Attitudes training issues and barriers for community nurses implementing an advance directive program. Perspectives 1997;21:3-8

81.

Molloy DW, Standish T. A guide to the standardized mini-mental state exam. Int Psychogeriatr 1997; 9:87-94.

82.

Patterson C, Molloy DW, Guyatt GH, Bédard M, North J, Hassard J, Willison K, Jubelius R, Darzins P Harrison C. Systematic implementation of an advance health care directive in the community. Can J Nurs. Admin. 1997;May-June:96-109

83.

Molloy DW, Guyatt G, Goeree R, Capretta R, Urbanyi M, Flett N, Bédard M.A comprehensive health care directive in a home for the aged for both competent and incompetent residents. Annals RCPSC 1997; 30:339-45.

84.

Patterson C, Molloy DW, Jubelius R, Guyatt GH, Bédard M. Provisional educational needs of health care providers in palliative care in three nursing homes in Ontario. Journal of Palliative Care 1997; 13-17.

85.

Bédard M, Molloy DW, Guyatt GH, Stones MJ, Strang DG. Medical screening of older drivers. Molloy DW, Bédard M. Jour. Amer. Geriatr. Soc. 1997; 45:38889.Competency to drive in cognitively impaired older adults. Annals RCPSC 1997; 30:346-52.

86.

Bédard M, Molloy DW, Pedlar D, Lever JA, Stones M. Associations between dysfunctional behaviors, gender and burden in spousal caregivers of cognitively impaired older adults. Int Psychogeriatr 1997; 9:277-90.

87.

Bédard M, Molloy DW, Guyatt G, Standish T. Self-administered and intervieweradministered instruments for dementia research. Clinical Gerontologist 1998; 19; 2:2535.

88.

Strang DG, Molloy DW, Harrison, C. Capacity to choose place of residence: autonomy vs. beneficence? Journal of Palliative Care 1998;14:1:25-9

89.

Bédard M, Molloy DW, Lever JA. Factors associated with motor vehicle crashes in cognitively-impaired older adults. Alzheimer Disease and Associated Disorders 1998:12:3:135-9

90.

Eismann M, Eriksson M, Molloy DW, Nordenstam M, Richter J. Attitudes towards self-determination in health care - a general population survey in Northern Sweden. European J Public Health 1999;9:41-4

91.

Etchells M, Darzins P, Silberfeld M, Singer PA, McKenny J, Naglie G, Katz M, Guyatt GH, Molloy DW, Strang D. Assessment of patient capacity to consent to treatment: Agreement between treating clinicians, mini-mental state scores, and expert assessments. J Gen Int Med 1999;14:27-34

92.

T Bédard M, Chambers L, Molloy DW, Lever J, Stones M, Martin N. The impact of Alzheimer’s disease on caregivers is gender specific. Annals RCPSC 1999;32:1:21-8

93.

Bédard M, Molloy DW. Institutionalization of the cognitively impaired individuals: a longitudinal study. Clinical Gerontologist 1999;20:3-22

94.

Burns A, Rossor M, Hecker, Gauthier S, Petit, Moller HJ, Rogers SL, Friedhoff; Molloy DW. The effects of donepezil in Alzheimer’s disease – results from a multinational trial. Member of the International Donepezil Study Group Dement Geriatr Cogn Disord 1999;10:237-44

95.

Molloy DW, Smith SD, Jubelius RM. The Ideal Detail Program – comprehensive, upto-date drug detailing. Health Law in Canada 1999;19:89-95

96.

Levine E, Bédard M, Molloy DW, Basilevsky A. Determinants of driver fatality risk in front impact fixed object collisions. Mature Medicine Canada Sept/Oct 1999:1-4

97.

Bédard M, Bonner A, Molloy DW, Martin NJ, Stones MJ. In-home assessments of Alzheimer’s patients: Reliability and validity of instruments measuring cognition and mood. Clinical Gerontologist 1999;21:3-10

98.

Bedard M, Molloy DW, Bell R, Lever J. Determinants and detection of low body mass index in community-dwelling adults with Alzheimer’s disease. Int Psychogeriatri 2000;12:87-98

99.

Molloy DW, Guyatt G, Jubelius R, Goeree R, O’Brien BJ, Bedard M, Wilan, Watson J, Patterson C, Harrison C, Standish T, Strang D, Darzins, Smith S, Dubois S. Systematic implementation of an advance directive program: a randomized trial in six nursing homes. JAMA 2000; 283:1437-44.

100.

Molloy DW, Russo R, Pedlar, Bedard M. Implementation of advance directives among community-dwelling veterans. Gerontologist 2000;4:1-5

101.

Molloy DW, Panisset M, Gauthier S. A phase III clinical trial of the safety and efficacy of cerebrolysin in Alzheimer’s disease and the Cerebrolysin Study Group. Korean J Clin Geri 2000;1:81-8.

102.

Technology and education seniors about advance directives Molloy DW. Stiller AK. Russo R. Clinical Gerontologist 2000;26 4-6

103.

Krajcik S, Molloy DW. Use of non-steroidal anti-inflammatory drugs (NSAIDs) in old age. Mature Medicine Canada January/February 2000; 1-5.

104.

Levine E, Bédard M, Molloy DW, Basilevsky A. Determinants of driver fatality risk in front impact fixed object collisions. Mature Medicine Canada Sept/Oct 1999;1-4

105.

Molloy DW, Standish TL. Clinical experience with Cerebrolysin. Brain Neurotransmission 2000;8-4

106.

Linder K, Bedard M, Molloy DW, Martin NJ, Lever JA. Changes in Medication use and functional status in community-dwelling Alzheimer's patients after specialized geriatric consultation. Clinical Gerontologist 2000; 22:3-4

107.

Lever J, Molloy DW, Vertessi A, Sanderson B, Pokoradi L, Tuttle I. Developing an integrated geriatric assessment database and protocol. Mature Medicine Canada October/November 2000; 3-4

108.

Loeb M, Wodchis W, Stiller A, Smith S, Jubelius R, Molloy DW. Colonization with multi-resistant bacteria and quality of life in residents of long-term care facilities Infection Control and Hospital Epidemiology 2000.

109.

Bedard M, Lever J, Molloy DW, Pedlar D, Raney M. The experience of primary and secondary caregivers caring for the same adult with Alzheimer's disease" Journal of Mental Health and Aging. 2001; 7:2.

110.

Stiller A, Molloy DW, Russo R, Dubois S, Kavsak H, Bedard M. Development and evaluation of a new instrument that measures barriers to implementing Advance Directives. J. Com. 2001; 8:4

111.

Strang G, Gagnon M, Molloy DW, Darzins P, Etchells E, Bedard M, Davidson W. Development of a standardized comprehensive “Ideal Drug Detail”, The Canadian Journal of Clinical Pharmacology 2001;8:2

112.

Bedard M, Molloy DW, Squire L, Dubois S, Lever J, O'Donnell M. The Zarit Burden Interview: A new 12-item short version, and a 4-item screening version for caregivers of community-dwelling, cognitively-impaired older adults., The Gerontologist 2001;41:652-657

113.

Vertesi A. Lever J, Molloy DW, Sanderson B, Tuttle I, Principi E, Pokoradi L. Use and interpretation of the standardized mini-mental state exam., Canadian Family Physician 2001;47:2018-2023

114.

Novack G, O'Donnell M, Molloy DW. New glaucoma medications in the geriatric population. Efficacy and safety. J Am Geriatr Soc 2002 50:956-62.

115.

Ward Alexandra, Caro J. Jaime, Kelley Heather, Eggleston Andrew, Molloy DW. Describing Cognitive Decline of Patients at the Mild or Moderate Stages of Alzheimer’s Disease Using the Standardized MMSE. International Psychogeriatrics, September 2002; 14:3 249-258 Springer Publishing Company, New York.

116.

Molloy DW, Strang D, Guyatt G, Lexchin J, Bedard M, Dubois S, Russo R. Assessing the Quality of Drug Detailing. Journal of Clinical Epidemiology 2002; 55: 825-832.

117.

Nadkarni, Neelesh K., Molloy DW. Optimal Management of Behavioural and Psychological Symptoms of Dementia. Geriatrics and Aging, February 2003;6:2 11-15

118.

Bedard M, Dubois S, Lever J, Minthorn, Biggs M, Molloy DW, O'Donnell M, Squire L. Validity of self-reports in dementia research: The Geriatric Depression Scale. in Clinical Gerontologist. 2003:26:155-163

119.

Caro, J., Ward, A., Ishak, K., Kelley, H., Raggio, G., Robinson, K., Eggleston, A., Molloy DW. What is the expected rate of cognitive decline for patients with Alzheimer’s disease? Long-term Care Interface, February 2003; 4:29-34

120.

Borrie MJ; Dalziel W; Fisher R; Molloy W; Puxty J. Physician supply: future tense. CMAJ. 2003 Oct 14;169(8):752;.

121.

Tran, Mun, Bedard, Michel, Molloy DW. Dubois, Sacha, Lever, Judith A. sociations between psychotic symptoms and dependence in activities of daily living among older adults with Alzheimer’s disease. International Psychogeriatrics 2003; 15:171-179

122.

Loeb,M, Molloy DW, Smieja, M, Standish,T, Goldsmith, CH, Mahony,J., Smith,S, Borrie,M, Decoteau,E, Davidson,W, McDougall,A, Gnarpe,J., O’Donnell,M, Chernesky,M. A randomized controlled trial of doxycycline and rifampin for patients with Alzheimer disease. J Am Geriatr Soc 2004;52:381-387

123.

Chan Carusone S, Smieja M, Molloy DW, Goldsmith C, Mahony J, Chernesky M, Gnarpe J, Standish T, Smith S, Loeb M. Lack of association between vascular dementia and chlamydia pneumoniae infection: a case-control study. BMC Neurology 2004, 4:15

124.

O’Donnell, M., Molloy DW; Smith S; Dubois S; Russo R. The Self-Perceived Role and Educational Needs of Pharmaceutical Representative: A Survey. Education for Health: Change in Learning and Practice, 2004;17:(3):12-15.

125.

B´edard M, Kuzik R, Chambers L, Molloy DW, Dubois S, Lever JA. Understanding burden differences between men and women caregivers: the contribution of carerecipient problem behaviors. International Psychogeriatrics 2005;17:99-118.

126.

Molloy DW, Standish T, Lewis DL. Screening for mild cognitive impairment: comparing the SMMSE and the ABCS. Can J Psychiatry 2005;50:52-58.

127.

Kanji J, Molloy DW, Standish T, Lewis DL, Chivers R. Reliability and validity of the AB Clock Test (ABCT): an objective approach to scoring the clock drawing test. McMaster University Medical Journal 2006;3:16-21.

128.

O’Donnell MJ, Lewis DL, Dubois S, Standish T, Bedard M, Molloy DW. Behavioral and Psychological Symptoms in Community-dwelling Elderly Persons with Cognitive Impairment and Dementia Prevalence and Factor Analysis. Clinical Gerontologist 2007;30:41-52.

129.

Kupferschmidt AL, Lewis DL, Molloy DW, Standish T, Babineau T. Using duration of memory loss to improve differentiation of mild cognitive impairment from normal cognition. Int J of Geriatr Psychiatry 2006, 21, 189-190

130.

Molloy DW, Cunje A, Standish T, Lewis DL. Alternate forms of Logical Memory and Verbal Fluency Tasks for Repeated Testing in Early Cognitive Changes. Int Psychogeriatr 2007; 19:65-75.

131.

Molloy DW, Standish, T, Dubois, S. A Short Screen for Depression: The AB Clinical Depression Screen (ABCDS). Int Psychogeriatr 2006; 18:481-92.

132.

Standish T, Molloy W, Cunje A, Lewis D.Do the ABCS 135 short cognitive screen and it subtests discriminate between normal cognition, mild cognitive impairment and dementia? Int J Geriatr Psychiatry. 2007; 22:189-194

133.

Molloy DW, Standish TI, Nieboer E, Turnbull J, Smith SD, Dubois S. Effects of Acute Exposure to Aluminum on Cognition in Humans. Journal of Toxicology and Environmental Health, Part A, 70: 2011–2019, 2007.

134.

Yavuz B.B., Standish T., Almeida E., Cunje A., DiLoreto P., Moore A., Kucher B., Marchese M., Warsi M., Molloy AJ, Molloy DWM Antibiotics in dementia: What’s next? The DARAD Trial. Akad Geriatri 2009;1:67-72.

135.

O Caoimh R, Gao Y, McGlade C, Healy L, Gallagher P, Timmons S, Molloy D W. Comparison of the Quick Mild Cognitive Impairment (Qmci) screen and the SMMSE in Screening for Mild Cognitive Impairment. Age Ageing 2012;41(5), 624-629

136.

Warsi M.A., Molloy D.W, Noseworthy M.D. (2012) Correlating brain blood oxygenation level dependent (BOLD) fractal dimension mapping with magnetic

resonance spectroscopy (MRS) in Alzheimer's disease. MAGMA. 2012 Oct; 25(5):335-44 137.

McGlade C, Molloy D.W, Timmons S. Decision-making in incompetetent older adults: Clinical, Social and Legal issues.Medico-legal Journal of Ireland 2011;17(2), 70-75.

138.

Molloy DW, Standish TI, Zhou Q, Guyatt G; The DARAD Study Group. A multicenter, blinded, randomized, factorial controlled trial of doxycycline and rifampin for treatment of Alzheimer's disease: the DARAD trial. Int J Geriatr Psychiatry. 2013; 8(25), 463-470

139.

O’Caoimh R, Gao Y, Gallagher P, Eustace J, McGlade C, Molloy D W. Which Part of the Quick Mild Cognitive Impairment Screen (Qmci) Discriminates Between Normal Cognition, Mild Cognitive Impairment and Dementia? Age and Ageing. 2013 (in press)

140.

Tran, M., Bédard, M. Dubois, S., Weaver, B. and Molloy, D.W. The influences of psychotic symptoms on the activities of daily living of individuals with Alzheimer disease: A longitudinal analysis Aging Ment Health. 2013; 42(3), 324-330

141.

Coffey, A., McCarthy, G., Weathers, E., Friedman, M. Isabel; Gallo, K., Ehrenfeld, M., Itzhaki, M., Chan, S., Li, W., Poletti, P., Zanotti, R., Molloy, D., McGlade, C., Fitzpatrick, J. ‘Nurses’ preferred end-of-life treatment choices in five countries International Nursing Review (in press)

142.

O’Caoimh, R., Molloy, W.D. Screening for Alzheimer’s Disease in Downs Syndrome. Journal of Alzheimer’s Disease and Parkinsonism. 2013 (in press)

143.

O’Caoimh R, Svendrovski A, Johnston B, Gao Y, McGlade C, Timmons S, Eustace J, Guyatt G, Molloy D.W. Comparison of the Quick Mild Cognitive Impairment Screen (Qmci) to the Standardised Alzheimer`s Disease Assessment Scale-cognitive section (SADAS-cog). Journal of Clinical Epidemiology 2013 (in press)

144.

O’Caoimh R, Gao Y, Healy L, Kerins D, Eustace J, Guyatt G, Sammon D, Molloy D.W. Effects of Centrally Acting Angiotensin Converting Enzyme Inhibitors on the Rate of Cognitive Decline in Dementia BMJ Open 2013 (in press)

145.

McGlade C., Molloy W., Timmons S. Decision Making in Incompetent Older Adults: Clinical, Social and Legal Issues. Medicolegal Journal of Ireland 2011 (in press).

Suggest Documents